DCF — ST JOSEPH MEDICAL CENTER
Enterprise Value: $-254.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-254.4M
Enterprise Value
$-83.5M
PV of Cash Flows
$-170.8M
PV of Terminal Value
$-275.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $249.9M | $-14.2M | -6.0% | $-24.8M | $-22.5M |
| Year 2 | $257.4M | $-12.0M | -5.0% | $-22.9M | $-18.9M |
| Year 3 | $265.1M | $-9.7M | -4.0% | $-21.0M | $-15.8M |
| Year 4 | $273.1M | $-8.7M | -3.0% | $-20.2M | $-13.8M |
| Year 5 | $281.3M | $-8.2M | -3.0% | $-20.1M | $-12.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-254.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$242.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.061752396432440584
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5